Brief: In8bio Announces Pricing Of Private Placement Of Up To $40.2 Million
Dec 19 (Reuters) - IN8bio Inc INAB.O: IN8BIO ANNOUNCES PRICING OF PRIVATE PLACEMENT OF UP TO $40.2 MILLION TO ADVANCE NOVEL GAMMA-DELTA T CELL ENGAGER IN8BIO INC: INITIAL PROCEEDS EXTEND CASH RUNWAY INTO FIRST HALF OF 2027 Source text: ID:nGNXYPnkp Further company coverage: INAB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall